Optimal Antiplatelet Therapy Post ACS PCI: Dual vs Single Agent Long-term treatment with oral anticoagulation (OAC) is crucial for patients with atrial fibrillation (AF), deep venous thrombosis, and other disorders for preventing thromboembolic events. Due to percutaneous coronary intervention (PCI) with stenting, 20% to 30% of these patients also indicate dual antiplatelet treatment (DAPT) with aspirin and clopidogrel. Therefore, selecting the best antithrombotic regimens for patients who have undergone coronary intervention and OAC might be difficult.
Is EF Relevant in the Medical Management of Heart Failure? The therapeutic objectives of heart failure with reduced ejection fraction differ from those of heart failure with preserved ejection fraction. The four pillars of disease-modifying therapy for the management of HF are mineralocorticoid receptor antagonists, beta-blockers, ACE…
